dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Tolaney, Sara M |
dc.contributor.author | Arteaga, Carlos |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Sohn, Joohyuk |
dc.contributor.author | Rugo, Hope |
dc.contributor.author | Bardia, Aditya |
dc.date.accessioned | 2021-10-22T09:06:05Z |
dc.date.available | 2021-10-22T09:06:05Z |
dc.date.issued | 2020-04 |
dc.identifier.citation | Rugo HS, Bardia A, Tolaney SM, Arteaga C, Cortes J, Sohn J, et al. TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer. Futur Oncol. 2020 Apr;16(12):705–715. |
dc.identifier.issn | 1744-8301 |
dc.identifier.uri | https://hdl.handle.net/11351/6446 |
dc.description | HER2 negatiu; Càncer de mama metastàsic; Sacituzumab govitecan |
dc.language.iso | eng |
dc.publisher | Future Medicine |
dc.relation.ispartofseries | Future Oncology;16(12) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Quimioteràpia |
dc.subject | Metàstasi |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Neoplasm Metastasis |
dc.title | TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.2217/fon-2020-0163 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | metástasis neoplásica |
dc.relation.publishversion | https://doi.org/10.2217/fon-2020-0163 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rugo HS] Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. [Bardia A] Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. [Tolaney SM] Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. [Arteaga C] Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. [Cortes J] Medical Oncology Department, IOB Institute of Oncology, Quirosalud Group, Madrid & Barcelona. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Sohn J] Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea |
dc.identifier.pmid | 32223649 |
dc.identifier.wos | 000532009800002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |